Literature DB >> 17452509

Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.

Timothy L Reudelhuber1, Kenneth E Bernstein, Patrick Delafontaine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17452509      PMCID： PMC3227117          DOI： 10.1161/HYPERTENSIONAHA.106.075085

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  46 in total

1.  Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart.

Authors:  J P van Kats; D Methot; P Paradis; D W Silversides; T L Reudelhuber
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

2.  Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts.

Authors:  M O Gray; C S Long; J E Kalinyak; H T Li; J S Karliner
Journal:  Cardiovasc Res       Date:  1998-11       Impact factor: 10.787

3.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice.

Authors:  A Subramaniam; W K Jones; J Gulick; S Wert; J Neumann; J Robbins
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

4.  Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.

Authors:  N Wettschureck; H Rütten; A Zywietz; D Gehring; T M Wilkie; J Chen; K R Chien; S Offermanns
Journal:  Nat Med       Date:  2001-11       Impact factor: 53.440

5.  Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

Authors:  Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

6.  Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system.

Authors:  L Mazzolai; J Nussberger; J F Aubert; D B Brunner; G Gabbiani; H R Brunner; T Pedrazzini
Journal:  Hypertension       Date:  1998-06       Impact factor: 10.190

7.  Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction.

Authors:  Y Nio; H Matsubara; S Murasawa; M Kanasaki; M Inada
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

8.  Hypertension in the transgenic rat TGR(mRen-2)27 may be due to enhanced kinetics of the reaction between mouse renin and rat angiotensinogen.

Authors:  Y Tokita; R Franco-Saenz; E M Reimann; P J Mulrow
Journal:  Hypertension       Date:  1994-04       Impact factor: 10.190

9.  Prognostic significance of left ventricular mass change during treatment of hypertension.

Authors:  Richard B Devereux; Kristian Wachtell; Eva Gerdts; Kurt Boman; Markku S Nieminen; Vasilios Papademetriou; Jens Rokkedal; Katherine Harris; Peter Aurup; Björn Dahlöf
Journal:  JAMA       Date:  2004-11-17       Impact factor: 56.272

10.  High blood pressure in transgenic mice carrying the rat angiotensinogen gene.

Authors:  S Kimura; J J Mullins; B Bunnemann; R Metzger; U Hilgenfeldt; F Zimmermann; H Jacob; K Fuxe; D Ganten; M Kaling
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598
View more
  32 in total

Review 1.  Intracardiac intracellular angiotensin system in diabetes.

Authors:  Rajesh Kumar; Qian Chen Yong; Candice M Thomas; Kenneth M Baker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

Review 2.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

3.  Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.

Authors:  Chih-Chang Wei; Naoki Hase; Yukiko Inoue; Eddie W Bradley; Eiji Yahiro; Ming Li; Nawazish Naqvi; Pamela C Powell; Ke Shi; Yoshimasa Takahashi; Keijiro Saku; Hidenori Urata; Louis J Dell'italia; Ahsan Husain
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 4.  The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.

Authors:  Xiao C Li; Jianfeng Zhang; Jia L Zhuo
Journal:  Pharmacol Res       Date:  2017-06-12       Impact factor: 7.658

5.  Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin ii, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7).

Authors:  Tiago Fernandes; Nara Y Hashimoto; Flávio C Magalhães; Fernanda B Fernandes; Dulce E Casarini; Adriana K Carmona; José E Krieger; M Ian Phillips; Edilamar M Oliveira
Journal:  Hypertension       Date:  2011-06-27       Impact factor: 10.190

6.  Sex differences in circulating and renal angiotensins of hypertensive mRen(2). Lewis but not normotensive Lewis rats.

Authors:  Karl D Pendergrass; Nancy T Pirro; Brian M Westwood; Carlos M Ferrario; K Bridget Brosnihan; Mark C Chappell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-02       Impact factor: 4.733

7.  Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility.

Authors:  Lihong Chen; Yifei Miao; Yahua Zhang; Dou Dou; Limei Liu; Xiaoyu Tian; Guangrui Yang; Dan Pu; Xiaoyan Zhang; Jihong Kang; Yuansheng Gao; Shiqiang Wang; Matthew D Breyer; Nanping Wang; Yi Zhu; Yu Huang; Richard M Breyer; Youfei Guan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-11       Impact factor: 8.311

8.  Distinct roles for angiotensin-converting enzyme 2 and carboxypeptidase A in the processing of angiotensins within the murine heart.

Authors:  Paul J Garabelli; J Gregory Modrall; Josef M Penninger; Carlos M Ferrario; Mark C Chappell
Journal:  Exp Physiol       Date:  2008-03-20       Impact factor: 2.969

Review 9.  The intracellular renin-angiotensin system in the heart.

Authors:  Rajesh Kumar; Vivek P Singh; Kenneth M Baker
Journal:  Curr Hypertens Rep       Date:  2009-04       Impact factor: 5.369

10.  Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy.

Authors:  Hong Yue; Wei Li; Russell Desnoyer; Sadashiva S Karnik
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.